JP2022548859A5 - - Google Patents

Info

Publication number
JP2022548859A5
JP2022548859A5 JP2022516164A JP2022516164A JP2022548859A5 JP 2022548859 A5 JP2022548859 A5 JP 2022548859A5 JP 2022516164 A JP2022516164 A JP 2022516164A JP 2022516164 A JP2022516164 A JP 2022516164A JP 2022548859 A5 JP2022548859 A5 JP 2022548859A5
Authority
JP
Japan
Prior art keywords
methyl
phenyl
thiazole
bromophenyl
sulfinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022516164A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022548859A (ja
Filing date
Publication date
Priority claimed from EP19197359.3A external-priority patent/EP3792252A1/en
Application filed filed Critical
Publication of JP2022548859A publication Critical patent/JP2022548859A/ja
Publication of JP2022548859A5 publication Critical patent/JP2022548859A5/ja
Pending legal-status Critical Current

Links

JP2022516164A 2019-09-13 2020-09-10 認知機能の改善における使用および物質依存症に対する使用のためのチアゾールおよびジフェニル置換スルホキシド Pending JP2022548859A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19197359.3 2019-09-13
EP19197359.3A EP3792252A1 (en) 2019-09-13 2019-09-13 Thiazole and diphenyl substituted sulfoxides for use in improving cognition functions and against addictions to substances.
PCT/EP2020/075338 WO2021048284A1 (en) 2019-09-13 2020-09-10 Thiazole and diphenyl substituted sulfoxides for use in improving cognition functions and against addictions to substances

Publications (2)

Publication Number Publication Date
JP2022548859A JP2022548859A (ja) 2022-11-22
JP2022548859A5 true JP2022548859A5 (https=) 2023-10-02

Family

ID=67956609

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022516164A Pending JP2022548859A (ja) 2019-09-13 2020-09-10 認知機能の改善における使用および物質依存症に対する使用のためのチアゾールおよびジフェニル置換スルホキシド

Country Status (7)

Country Link
US (1) US12612374B2 (https=)
EP (1) EP3792252A1 (https=)
JP (1) JP2022548859A (https=)
KR (1) KR20220062376A (https=)
CN (1) CN114401948A (https=)
CA (1) CA3154003A1 (https=)
WO (1) WO2021048284A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114917350B (zh) * 2022-06-21 2023-06-13 重庆医科大学附属第二医院 Cftr增强剂在注意缺陷与多动障碍中的应用及产品

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670358B2 (en) 2000-05-16 2003-12-30 Cephalon, Inc. Substituted thioacetamides
JP4394451B2 (ja) 2002-01-04 2010-01-06 ニューロサーチ、アクティーゼルスカブ カリウムチャネルモジュレーター
EP1472214A2 (en) 2002-02-08 2004-11-03 SmithKline Beecham Corporation Compounds for inhibiting insulin secretion and methods related thereto
EP2292213A1 (en) 2004-02-06 2011-03-09 Cephalon, Inc. Compositions comprising a polymorphic form of armodafinil
US7314875B2 (en) 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
NZ619408A (en) * 2009-03-11 2015-08-28 Omeros Corp Compositions and methods for prophylaxis and treatment of addictions
CA2989243C (en) * 2014-08-13 2023-03-14 Red Bull Gmbh Heterocyclic compounds with working memory enhancing activity
CN107522693B (zh) * 2017-08-15 2018-12-04 北京豪思生物科技有限公司 一种6-元芳香环或杂芳香环化合物及其制备方法和应用
EP3553053A1 (en) * 2018-04-12 2019-10-16 Red Bull GmbH (s)-enantiomeric form of a heterocyclic compound having motivation improving and/or reference memory enhancing activity

Similar Documents

Publication Publication Date Title
JP2020023528A5 (https=)
JP2018070614A5 (https=)
US9975868B2 (en) 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto
RU2386633C2 (ru) 1h-индазолы, бензотиазолы, 1, 2-бензоизоксазолы, 1, 2-бензоизотиазолы и хромоны и их получение и применения
JP2015531764A5 (https=)
JP2007538024A5 (https=)
JP2020502092A5 (https=)
JP2009504748A5 (https=)
JP2004526788A5 (https=)
JP2004534816A5 (https=)
JP2022539152A5 (https=)
JP2022519744A5 (https=)
HRP20180109T1 (hr) Inhibitori gsk-3
JP2010522711A5 (https=)
RU2005141060A (ru) Метаболит кветиапина
JP2009500425A (ja) エスゾピクロン及びトランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−n−メチル−1−ナフタレンアミン又はトランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−1−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
RS60556B1 (sr) Kondenzovani benzazepini za lečenje mucanja
JP2022548859A5 (https=)
JP2016537432A5 (https=)
JP2005508381A5 (https=)
JP2015521643A5 (https=)
JP2023522307A5 (https=)
JP2015509105A (ja) リファキシミン誘導体及びその使用
JP2010520299A (ja) 3−アリール−3−ヒドロキシ−2−アミノ−プロピオン酸アミド、3−ヘテロアリール−3−ヒドロキシ−2−アミノ−プロピオン酸アミドおよび関連化合物を使用する認知障害の処置方法
AR069904A1 (es) Usos terapeuticos de compuestos con afinidad con el transportador de serotonina, los receptores de serotonina y el transportador de noradrenalina como por ejemplo, la 4-[2-(4-metilfenilsulfanil)fenil]piperidina y sus sales terapeuticamente aceptables